A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Single Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of DS-1040b when Added to Standard of Care Anticoagulation

  • Smyth, Susan (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date10/5/17 → 7/7/20